For the Quarter Ending September 2025
North America
• In United States, Ofloxacin Price Index rose in Q3 2025, driven by rising costs and strong pharmaceutical market sentiment.
• Ofloxacin production costs increased in Q3 2025, influenced by 2.6% PPI rise by August 2025.
• Rising input prices and strengthened industrial electricity in September 2025 elevated Ofloxacin expenses.
• Ofloxacin demand was positive, supported by strengthened pharmaceutical market sentiment and surging drug approvals in Q3 2025.
• Robust consumer spending, retail sales up 5.42% in September 2025, supported patient access and Ofloxacin demand.
• Low unemployment rate of 4.3% in September 2025 contributed to stable healthcare spending and Ofloxacin demand.
• US manufacturing inventories tightened in Q3 2025, and chemical output slipped, impacting Ofloxacin supply.
• Henry Hub natural gas prices inched up from August to September 2025, increasing Ofloxacin energy costs.
• Declining consumer confidence to 94.2 in September 2025 may temper future Ofloxacin demand.
Why did the price of Ofloxacin change in September 2025 in North America?
• Ofloxacin production costs rose from 2.6% PPI increase by August 2025.
• Strong pharmaceutical sentiment and 5.42% retail sales growth in September 2025 boosted demand.
• Tightened US manufacturing inventories and decelerated output growth in Q3 2025 pressured prices.
APAC
• In China, Ofloxacin Price Index fell in Q3 2025, influenced by falling factory-gate prices and subdued consumer confidence.
• Ofloxacin production costs increased in Q3 2025 due to rising natural gas prices and higher demand for chemical intermediates.
• Ofloxacin demand outlook was mixed; retail sales grew 3.0% in September 2025, but consumer confidence was low.
• China's industrial production expanded 6.5% year-on-year in September 2025, supporting stable supply of Ofloxacin inputs.
• The Manufacturing Index was contracting in September 2025, reflecting a slowdown in the broader chemical industry.
• Deflationary pressures, with CPI falling 0.3% year-on-year in September 2025, impacted consumer purchasing power.
• Pharmaceutical goods exports from China inched down August-September 2025, while imports saw a more significant decline.
• Ofloxacin price forecast suggests continued pressure from weak domestic demand and persistent chemical oversupply.
Why did the price of Ofloxacin change in September 2025 in APAC?
• Producer prices fell 2.3% in September 2025, pressuring Ofloxacin selling prices downward.
• Consumer confidence at 89.6 in September 2025 reflected pessimism, moderating Ofloxacin demand.
• Rising natural gas prices in Q3 2025 contributed to increased production costs for Ofloxacin intermediates.
Europe
• In Germany, the Ofloxacin Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs.
• Ofloxacin production costs increased in Q3 2025, influenced by elevated energy prices for German businesses.
• Demand for Ofloxacin faced headwinds in Q3 2025 as Germany's Manufacturing Index was contracting in September 2025.
• A low 3.9% unemployment rate in September 2025 supported Ofloxacin demand by bolstering consumer purchasing power.
• Overall industrial output declined by -1.0% year-over-year in September 2025, indicating a weaker economic environment.
• Consumer confidence remained significantly negative at -23.6 in September 2025, impacting discretionary healthcare spending.
• German chemical exports faced weak demand in Q3 2025, while European sales stagnated, affecting Ofloxacin trade.
• The pharmaceutical market in Germany experienced moderate growth in 2025, driven by an aging population and chronic diseases.
Why did the price of Ofloxacin change in September 2025 in Europe?
• Elevated energy costs in Q3 2025 increased Ofloxacin production expenses in Germany.
• German pharmaceutical industry faced increased price and cost pressure during Q3 2025.
• Producer prices declined by -1.7% in September 2025, moderating Ofloxacin input cost increases.
For the Quarter Ending June 2023
North America
Across the North American region, the prices of Ofloxacin demonstrate a mixed price trajectory throughout the second quarter of 2023. At the beginning of the second quarter, the prices continued to follow the market trend of the previous month resulting in a steady rising inquiry from the domestic pharmaceutical and healthcare sector.
However, in May, ofloxacin prices went down by 2 percent from the previous month. The combination of decreased demand, increased supply, and a weakening currency has led to a decline in Ofloxacin prices in the USA this month. In recent months, both countries, China and India, being the major supplier of Pharmaceutical API, including Ofloxacin, have increased production to meet the growing demand, resulting in higher stocks.
Also, the weakening of the US dollar against other currencies supported this month’s decreased trade as this has made Ofloxacin more expensive for buyers in the US, which has reduced demand and put further downward pressure on prices. However, the prices rebounded again in June but steadily. Also, the domestic Ofloxacin suppliers have a sizable supply on hand that allows them to meet local demand. Moreover, the US Consumer Price Index (CPI) rose by 0.1% in June 2023 from May. With this, the prices for Ofloxacin get settled at USD 41650/MT CFR Los Angeles.
Asia Pacific
During the second quarter, the price of Ofloxacin, an Active Pharmaceutical Ingredient, demonstrated a zigzag market sentiment throughout the second quarter of 2023, as at the beginning of April. The price surged moderately, followed by the market sentiments of the previous month. Consumption remained consistent in April in both the domestic and global markets. Furthermore, export activities from China stayed on the upper side because of a persistent inquiry from the international market. Moreover, towards the middle of the second quarter, the prices began to drop and decreased by around 4 percent. This price decrease was supported by ample inventories among the merchants, followed by reduced export momentum. Also, the strengthening of the Chinese Yuan against the US dollar in recent months has made various end-products, including Ofloxacin, more expensive for buyers in other countries, owing to which the traders and manufacturers reduced their prices even more, to balance out their market outlook. Following this, the market improved for pharmaceutical API with the termination of Q2-2023. According to market experts, China’s Consumer Price Index (CPI) rose by 0.2% in June 2023 from May, but manufacturing remained weak. With this, Ofloxacin API prices across the region market were settled at USD 4810/MT FOB Shanghai.
Europe
For the whole second quarter, the prices of Ofloxacin depict a parallel market trend as that of the United States. The prices continued upward until April while dropping significantly in May and rebounding stably in June. April’s price trend was supported by consistent demand balanced with continuous manufacturing activities and supplies among the merchants. While as May 2023 approached, the prices went down by more than 5 percent and settled at USD 24500/MT. This price trend was attributed to a drop in international inquiries and changes in climatic conditions that resulted in lessened orders sentiments from retailers and suppliers, as hotter climatic might degrade the medicines and their raw material. Also, this month’s prices were further supported by the weakened German Purchasing Manager Index (PMI) for Germany, which was 52.2, down from 54.8 in May. Moving towards the end of Q2, the prices for Ofloxacin were assembled at USD 46650/MT CFR Hamburg, demonstrating a stable incremented trend with participants ensuring enough stocks to meet overall demand.
For the Quarter Ending March 2023
North America
With a significant increase in domestic demand and constrained supply among market players, the price of Ofloxacin rose during the first quarter of 2023. In early January 2023, Ofloxacin inventories among market participants were sufficient to meet all needs, as opposed to December 2022. By the middle of the first quarter, a slowdown in trade activity and a steady increase in demand forced traders and suppliers to raise their quotes, further supporting the upward price trend for Ofloxacin. Overall, the cost of Ofloxacin in the United States was constructed at USD 47640/MT CFR Los Angeles.
Asia Pacific
Prices for Ofloxacin increased throughout the first quarter of 2023 in the APAC area as a result of heightened demand following the Lunar New Year and the government abandoning its zero-COVID policy. Both consumption and output notably surged during the holiday-shortened month of January in China. The producers were forced to increase production and stock their shelves with downstream of Ofloxacin before the end of the quarter. Moreover, ease in trade activity along with a decrease in freight charges, further supported the upsurged market trend of Ofloxacin in the APAC region. With this, prices increased at a modest rate and reached USD 46680/MT FOB Shanghai.
Europe
The first quarter of 2023 saw a strong upward pricing trend for Ofloxacin as queries from the downstream sector substantially increased. Furthermore, as 2023 approaches, commerce between Germany and China climbed to a record level despite political worries about over-dependence, becoming China Germany's top trading partner for the seventh consecutive year. Early in January, a balance between supply and demand was seen in the local market, but as February drew closer, the price went on the higher side consistently, which helped the market participants to raise their prices of Ofloxacin. Additionally, increased trade activity and persistent inquiries from exporting nations strengthened the Ofloxacin market value through the end of March 2023. With this, the prices for Ofloxacin settled at USD 48800/ MT CFR Hamburg.
For the Quarter Ending December 2022
North America
North American region, particularly the USA, witnessed an inclined price trend for Ofloxacin during the start of October. Increased end-user demand balanced with enough supplies among the market participants kept the prices of Ofloxacin on the higher side. Slowing economic activity amid rising borrowing costs, Consumer spending, which edged up 0.1% after surging 0.9% in October, and ease in trade disruption along with shipment cost supported the market sentiments of Ofloxacin in the USA. Towards the mid of the fourth quarter till the end of 2022, the prices fell significantly with the settlement of USD 46155/ MT CFR Los Angeles backed by decremented inquiries coupled with the temporary shutdown of the domestic market owing to New-year holidays.
APAC
The prices of Ofloxacin plummeted at the end of 2022 in the Asia Pacific region, primarily in China. With the start of the fourth quarter, i.e., during October, the prices of Ofloxacin demonstrated a positive market outlook as the demand inclined considerably with an increase in supply chain activity. Following November, demand in China started to drop gradually, with sufficient stocks among the market participants to meet all immediate orders. The price of Ofloxacin got settled at USD 44750/MT FOB Shanghai. Following December, an outburst of lockdowns of COVID-19 muted economic output and affected the market sentiments of all the commodities, including Ofloxacin, in China.
Europe
During the fourth quarter of 2022, the European market for Ofloxacin imitated a similar pattern as that of North America. The market initially started on a weaker note up to November as the demand from the end-user sector pharmaceutical industry decreased, balanced with the overall supplies among the market participants. After November, demand for Ofloxacin increased slightly, keeping the prices on the stable side. The prices of Ofloxacin until November were gathered at USD 46100 /MT CFR Hamburg in Germany. At the same time, Fresher quotations from, Traders and inquiries from suppliers decreased in December of 2022 because of higher stock reserved with market players due to the market's brief closure on account of Christmas and New Year's eve.
